World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
131
Citations
92187
World Ranking
2346
National Ranking
1323

Research.com Recognitions

  • 2017 - Fellow of the American Statistical Association (ASA)

Overview

Kenneth R. Hess was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, and Molecular Biology.

The primary topics addressed in their work included Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Cancer Survivorship and Care, Cancer Treatment and Pharmacology, and Cancer Genomics and Diagnostics.

They published research in several prominent venues, frequently contributing to these journals:

  • Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • Journal of Clinical Oncology
  • British Journal of Cancer
  • ESMO Open

Their recent papers included:

  • Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer, 2023, Journal of Clinical Oncology
  • Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial, 2020, Journal for ImmunoTherapy of Cancer
  • Phase 2 study of pembrolizumab in patients with advanced rare cancers, 2020, Journal for ImmunoTherapy of Cancer
  • Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials, 2020, British Journal of Cancer
  • Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC, 2020, Journal of Thoracic Oncology

The scientist collaborated frequently with peers including Bora Lim, Vicente Valero, Naoto T. Ueno, David S. Hong, and Debu Tripathy.

In recognition of their professional contributions, Kenneth R. Hess was awarded the title of Fellow of the American Statistical Association (ASA) in 2017.

Best Publications

  • AJCC Cancer Staging Manual

    Mahul B. Amin;Stephen B. Edge;Frederick L. Greene;David R. Byrd

  • A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

    Michel Lacroix;Dima Abi-Said;Daryl R. Fourney;Ziya L. Gokaslan

  • Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

    Cornelia Liedtke;Chafika Mazouni;Kenneth R. Hess;Fabrice André

  • Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

    Eric L Chang;Jeffrey S Wefel;Kenneth R Hess;Pamela K Allen

  • Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

    Roman Rouzier;Charles M. Perou;W. Fraser Symmans;Nuhad Ibrahim

  • Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

    Eddie K. Abdalla;Jean-Nicolas Vauthey;Lee M. Ellis;Vickie Ellis

  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

    Jeffrey E. Gershenwald;Richard A. Scolyer;Kenneth R. Hess;Vernon K. Sondak

  • Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

    Michele Ceccarelli;Floris P Barthel;Tathiane M Malta;Thais S Sabedot

  • Experience with 1509 patients undergoing thoracoabdominal aortic operations

    Lars G. Svensson;E.Stanley Crawford;Kenneth R. Hess;Joseph S. Coselli

  • The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne

  • Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients

    E. Stanley Crawford;John L. Crawford;Hazim J. Safi;Joseph S. Coselli

  • Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

    Eric T. Wong;Kenneth R. Hess;Mary Jo Gleason;Kurt A. Jaeckle

  • Metastatic patterns in adenocarcinoma

    Kenneth R. Hess;Gauri R. Varadhachary;Sarah H. Taylor;Wei Wei

  • Deep hypothermia with circulatory arrest. Determinants of stroke and early mortality in 656 patients

    L. G. Svensson;E. S. Crawford;K. R. Hess;J. S. Coselli

  • Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

    Kenneth R. Hess;Keith Anderson;W. Fraser Symmans;Vicente Valero

  • Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study

    James C. Yao;Alexandria T. Phan;David Z. Chang;Robert A. Wolff

  • Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors

    Raymond Sawaya;Maarouf Hammoud;Derek Schoppa;Kenneth R. Hess

  • Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial

    Anita Mahajan;Salmaan Ahmed;Mary Frances McAleer;Jeffrey S Weinberg

  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

    Jennifer L. McQuade;Carrie R. Daniel;Kenneth R. Hess;Carmen Mak

  • Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer.

    M. Ayers;W.F. Symmans;J. Stec;A.I. Damokosh

Frequent Co-Authors

David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Filip Janku
Filip Janku The University of Texas MD Anderson Cancer Center
Sarina Anne Piha-Paul
Sarina Anne Piha-Paul The University of Texas MD Anderson Cancer Center
Apostolia Maria Tsimberidou
Apostolia Maria Tsimberidou The University of Texas MD Anderson Cancer Center
Razelle Kurzrock
Razelle Kurzrock Medical College of Wisconsin
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center
Lajos Pusztai
Lajos Pusztai Yale University
James L. Abbruzzese
James L. Abbruzzese Duke University
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but seeking flexible or alternative pathways? There are now a variety of online programs available for those looking to advance or start their medical careers without sacrificing work or family commitments. For registered nurses, rn to bsn programs no clinicals offer a convenient way to upgrade qualifications through coursework alone—no in-person clinicals required.

If you are hoping to achieve a Doctor of Nursing Practice, you may consider the dnp online programs that can be completed in less time due to their accelerated formats. For added flexibility, some of the online dnp programs without clinicals let working professionals earn advanced degrees without traditional hands-on requirements.

For those just beginning in nursing, lpn fast track program options can provide a quick start to a rewarding career. These streamlined courses facilitate faster entry into the workforce, making them a popular choice for career changers and recent graduates alike.

Best Scientists Citing Kenneth R. Hess

Recently Published Articles